Difficulty: Medium
Average Score: 95%
Practice
All of the following drugs destroy disulfide bonds of proteoglycans, which causes depolymerization and reduction of viscosity of sputum, EXCEPT:
Correct answer
C
Rationale
In this question on lifespan pharmacology, the correct answer is C) Deoxyribonuclease. Deoxyribonuclease does not destroy disulfide bonds of proteoglycans, which are critical for maintaining the structure and function of mucus in the respiratory tract. Proteoglycans play a significant role in the viscosity of sputum, and drugs that disrupt their disulfide bonds can aid in reducing sputum viscosity.
Acetylcysteine (Option A), Ambroxol (Option B), and Bromhexine (Option D) are mucolytic agents that act by breaking down disulfide bonds of proteoglycans, leading to depolymerization and reducing sputum viscosity. Acetylcysteine works by directly cleaving disulfide bonds, while Ambroxol and Bromhexine enhance the activity of endogenous enzymes that break down these bonds.
Understanding the mechanism of action of these drugs is crucial for healthcare professionals managing patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis. By knowing how these medications work, healthcare providers can make informed decisions when selecting the most appropriate treatment options for their patients based on the underlying pathophysiology of the condition.
Acetylcysteine (Option A), Ambroxol (Option B), and Bromhexine (Option D) are mucolytic agents that act by breaking down disulfide bonds of proteoglycans, leading to depolymerization and reducing sputum viscosity. Acetylcysteine works by directly cleaving disulfide bonds, while Ambroxol and Bromhexine enhance the activity of endogenous enzymes that break down these bonds.
Understanding the mechanism of action of these drugs is crucial for healthcare professionals managing patients with respiratory conditions such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis. By knowing how these medications work, healthcare providers can make informed decisions when selecting the most appropriate treatment options for their patients based on the underlying pathophysiology of the condition.